{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:56:38Z","timestamp":1793390198053,"version":"4.5.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ministerio de Ciencia, Tecnologia e innovaci\u00f3n","award":["PROGRAMA DE INVESTIGACI\u00d3N Y DESARROLLO EN CANNABIS Proyecto 11A"],"award-info":[{"award-number":["PROGRAMA DE INVESTIGACI\u00d3N Y DESARROLLO EN CANNABIS Proyecto 11A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cannabis Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-alcoholic fatty liver disease (NAFLD) is a common liver disorder caused by oxidative stress and dysregulation of lipid metabolism. The endocannabinoid system (ECS), particularly the type 1 cannabinoid (CB1) receptor, plays a crucial role in NAFLD progression. Cannabinoids, such as cannabidiol (CBD) and tetrahydrocannabinol (THC), along with terpenes, such as beta-myrcene and d-limonene, have shown potential therapeutic effects on liver health, particularly in reducing oxidative stress and modulating lipid metabolism. This study aimed to analyse the effects of five cannabis oils (COs), each with different CBD:THC ratios and terpenes content, on hypertension, dyslipidemia, hepatic steatosis, oxidative stress, and CB1 receptor expression in an experimental model of NAFLD induced by a sucrose-rich diet (SRD) in Wistar rats for 3 weeks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Male Wistar rats were fed either a: (1) reference diet (RD; standard commercial laboratory diet) or a: (2) sucrose-rich diet (SRD) for 3 weeks. 3 to 7 SRD\u2009+\u2009CO as following: (3) SRD\u2009+\u2009THC; (4) SRD\u2009+\u2009CBD; (5) SRD\u2009+\u2009CBD:THC 1:1; (6) SRD\u2009+\u2009CBD:THC 2:1; and (7) SRD\u2009+\u2009CBD:THC 3:1. The COs were administered orally at a dose of 1.5\u00a0mg total cannabinoids\/kg body weight daily. The cannabinoid and terpenes content of all COs used in the study was determined. The terpenes found in COs were beta-myrcene, d-limonene, terpinolene, linalool, beta-caryophyllene, alpha-humulene, (-)-guaiol, (-)-alpha-bisabolol. During the experimental period, body weight, food intake and blood pressure were measured. Serum glucose, triglyceride, total cholesterol, uric acid, alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (AP) levels were evaluated. Liver tissue histology, NAFLD activity score (NAS), triglyceride and cholesterol content, lipogenic enzyme activities, enzyme related to mitochondrial fatty acid oxidation, reactive oxygen species (ROS), thiobarbituric acid reactive substance (TBARS), and antioxidant enzyme activities were also evaluated. The CB1 receptor expression was also determined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The results showed that SRD-fed rats developed hypertension, dyslipidemia, liver damage, hepatic steatosis, lipid peroxidation, and oxidative stress. This was accompanied by upregulation of liver CB1 receptor expression. CBD-rich CO, CBD:THC 1:1 ratio CO; CBD:THC 2:1 ratio CO and CBD:THC 3:1 ratio CO showed antihypertensive properties. THC-rich CO, CBD:THC 1:1 ratio CO; CBD:THC 2:1 ratio CO showed the greatest beneficial effects against hepatic steatosis and liver damage. All COs exhibited antioxidant effects in liver tissue. This was associated with normal liver CB1 receptor expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study demonstrated that COs, particularly THC-rich CO, CBD:THC ratio 1:1 CO, CBD:THC ratio 2:1 CO and terpenes, can effectively reduce dyslipidemia, liver damage and hepatic steatosis in SRD-induced NAFLD. COs with a higher proportion of CBD in their composition showed antihypertensive properties. All the COs exhibited antioxidant properties. These findings suggest that COs, especially those with CBD:THC ratios of 1:1 and 2:1 and terpenes, may represent a promising therapeutic approach for managing NAFLD and preventing its progression to more severe liver disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42238-025-00286-8","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T16:53:37Z","timestamp":1752512017000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effects of five cannabis oils with different CBD: THC ratios and terpenes on hypertension, dyslipidemia, hepatic steatosis, oxidative stress, and CB1 receptor in an experimental model"],"prefix":"10.1186","volume":"7","author":[{"given":"Valentina","family":"Degrave","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle Berenice","family":"Vega Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Filippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Ingaramo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Torregiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamile Soledad","family":"Caro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Mercedes","family":"De Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Eugenia","family":"D\u2019Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Eugenia","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"issue":"3","key":"286_CR1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/tox.22523","volume":"33","author":"SB Ahmad","year":"2018","unstructured":"Ahmad SB, Rehman MU, Fatima B, Ahmad B, Hussain I, Ahmad SP, Farooq A, Muzamil S, Razzaq R, Rashid SM, Ahmad Bhat S, Mir MUR. Antifibrotic effects of d-limonene (5(1-methyl-4-[1-methylethenyl]) cyclohexane) in CCl4 induced liver toxicity in Wistar rats. Environ Toxicol. 2018;33(3):361\u20139. https:\/\/doi.org\/10.1002\/tox.22523.","journal-title":"Environ Toxicol"},{"issue":"9","key":"286_CR2","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.3390\/antiox12091653","volume":"12","author":"A Allameh","year":"2023","unstructured":"Allameh A, Niayesh-Mehr R, Aliarab A, Sebastiani G, Pantopoulos K. Oxidative stress in liver pathophysiology and disease. Antioxid (Basel). 2023;12(9):1653. https:\/\/doi.org\/10.3390\/antiox12091653.","journal-title":"Antioxid (Basel)"},{"key":"286_CR3","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.3390\/ijms26031306","volume":"26","author":"E Aloisio Caruso","year":"2025","unstructured":"Aloisio Caruso E, De Nunzio V, Tutino V, Notarnicola M. The endocannabinoid system: implications in Gastrointestinal physiology and pathology. Int J Mol Sci. 2025;26:1306. https:\/\/doi.org\/10.3390\/ijms26031306.","journal-title":"Int J Mol Sci"},{"issue":"40","key":"286_CR4","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.2174\/0929867323666160907123559","volume":"23","author":"JM Alves-Silva","year":"2016","unstructured":"Alves-Silva JM, Zuzarte M, Marques C, Salgueiro L, Girao H. Protective effects of terpenes on the cardiovascular system: current advances and future perspectives. Curr Med Chem. 2016;23(40):4559\u2013600. https:\/\/doi.org\/10.2174\/0929867323666160907123559.","journal-title":"Curr Med Chem"},{"issue":"11","key":"286_CR5","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.3390\/ph17111543","volume":"17","author":"R Andr\u00e9","year":"2024","unstructured":"Andr\u00e9 R, Gomes AP, Pereira-Leite C, Marques-da-Costa A, Monteiro Rodrigues L, Sassano M, Rijo P, Costa MDC. The entourage effect in Cannabis medicinal products: A comprehensive review. Pharmaceuticals (Basel). 2024;17(11):1543. https:\/\/doi.org\/10.3390\/ph17111543.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"286_CR6","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3390\/antiox10020174","volume":"26","author":"JC Arroyave-Ospina","year":"2021","unstructured":"Arroyave-Ospina JC, Wu Z, Geng Y, Moshage H. Role of oxidative stress in the pathogenesis of Non-Alcoholic fatty liver disease: implications for prevention and therapy. Antioxid (Basel). 2021;26(2):174. https:\/\/doi.org\/10.3390\/antiox10020174.","journal-title":"Antioxid (Basel)"},{"key":"286_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1089\/can.2020.0013","volume":"5","author":"T Assa Glazer","year":"2020","unstructured":"Assa Glazer T, Gorelick J, Sela N, Nyska A, Bernstein N, Zecharia M. Cannabis extracts affected metabolic syndrome parameters in mice fed High-Fat\/Cholesterol diet. Cannabis Cannabinoid Res. 2020;5:202\u201314. https:\/\/doi.org\/10.1089\/can.2020.0013.","journal-title":"Cannabis Cannabinoid Res"},{"key":"286_CR8","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.fct.2017.09.020","volume":"110","author":"M Bacanli","year":"2017","unstructured":"Bacanli M, Anlar HG, Ayd\u0131n S, \u00c7al T, Ar\u0131 N, \u00dcnde\u011fer Bucurgat \u00dc, Ba\u015faran AA. Ba\u015faran N. d-limonene ameliorates diabetes and its complications in streptozotocin-induced diabetic rats. Food Chem Toxicol. 2017;110:434\u201342. https:\/\/doi.org\/10.1016\/j.fct.2017.09.020.","journal-title":"Food Chem Toxicol"},{"issue":"2","key":"286_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00210-016-1326-3","volume":"390","author":"MD Baldissera","year":"2017","unstructured":"Baldissera MD, Souza CF, Grando TH, Doleski PH, Boligon AA, Stefani LM, Monteiro SG. Hypolipidemic effect of \u03b2-caryophyllene to treat hyperlipidemic rats. Naunyn Schmiedebergs Arch Pharmacol. 2017;390(2):215\u201323. https:\/\/doi.org\/10.1007\/s00210-016-1326-3.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"286_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2015.12.019","author":"RH Basha","year":"2016","unstructured":"Basha RH, Sankaranarayanan C. \u03b2-Caryophyllene, a natural sesquiterpene lactone attenuates hyperglycemia mediated oxidative and inflammatory stress in experimental diabetic rats. Chem Biol Interact. 2016. https:\/\/doi.org\/10.1016\/j.cbi.2015.12.019. 5;245:50\u2013\u20098.","journal-title":"Chem Biol Interact"},{"issue":"10","key":"286_CR11","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.3390\/ijms20102516","volume":"22","author":"I Bazwinsky-Wutschke","year":"2019","unstructured":"Bazwinsky-Wutschke I, Zipprich A, Dehghani F. Endocannabinoid system in hepatic glucose metabolism, fatty liver disease, and cirrhosis. Int J Mol Sci. 2019;22(10):2516. https:\/\/doi.org\/10.3390\/ijms20102516.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"286_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3390\/jcm10030393","volume":"10","author":"K Berk","year":"2021","unstructured":"Berk K, Bzdega W, Konstantynowicz-Nowicka K, Charytoniuk T, Zywno H, Chabowski A. Phytocannabinoids-A green approach toward Non-Alcoholic fatty liver disease treatment. J Clin Med. 2021;10(3):393. https:\/\/doi.org\/10.3390\/jcm10030393.","journal-title":"J Clin Med"},{"issue":"8","key":"286_CR13","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016;65(8):1038\u201348. https:\/\/doi.org\/10.1016\/j.metabol.2015.12.012.","journal-title":"Metabolism"},{"issue":"10","key":"286_CR14","doi-asserted-by":"publisher","first-page":"e0206152","DOI":"10.1371\/journal.pone.0206152","volume":"13","author":"E Chang","year":"2018","unstructured":"Chang E, Kim DH, Yang H, Lee DH, Bae SH, Park CY. Receptor receptor Blockade ameliorates hepatic fat infiltration and inflammation and increases Nrf2-AMPK pathway in a rat model of severely uncontrolled diabetes. PLoS ONE. 2018;13(10):e0206152. https:\/\/doi.org\/10.1371\/journal.pone.0206152.","journal-title":"PLoS ONE"},{"issue":"6","key":"286_CR15","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.3390\/ijms23063083","volume":"23","author":"T Charytoniuk","year":"2022","unstructured":"Charytoniuk T, Zywno H, Berk K, Bzdega W, Kolakowski A, Chabowski A, Konstantynowicz-Nowicka K. The endocannabinoid system and physical Activity-A robust duo in the novel therapeutic approach against metabolic disorders. Int J Mol Sci. 2022;23(6):3083. https:\/\/doi.org\/10.3390\/ijms23063083.","journal-title":"Int J Mol Sci"},{"key":"286_CR16","doi-asserted-by":"publisher","unstructured":"Chen S, Kim JK. The Role of Cannabidiol in Liver Disease: A Systemic Review. Int J Mol Sci. 2024; 17;25(4):2370. https:\/\/doi.org\/10.3390\/ijms25042370","DOI":"10.3390\/ijms25042370"},{"key":"286_CR17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","volume":"152","author":"Z Chen","year":"2020","unstructured":"Chen Z, Tian R, She Z, Cai J, Li H. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radic Biol Med. 2020;152:116\u201341. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.02.025.","journal-title":"Free Radic Biol Med"},{"key":"286_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/00236772211016926","volume":"56","author":"KC Chesler","year":"2022","unstructured":"Chesler KC, Motz CT, Bales KL, Allen RA, Vo HK, Pardue MT. Voluntary oral dosing for precise experimental compound delivery in adult rats. Lab Anim. 2022;56:147\u201356. https:\/\/doi.org\/10.1177\/00236772211016926.","journal-title":"Lab Anim"},{"issue":"25","key":"286_CR19","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.1007\/s00216-018-1260-y","volume":"410","author":"CK Chua","year":"2018","unstructured":"Chua CK, Lu B, Lv Y, Gu XY, Di Thng A, Zhang HJ. An optimized band-target entropy minimization for mass spectral reconstruction of severely co-eluting and trace-level components. Anal Bioanal Chem. 2018;410(25):6549\u201360. https:\/\/doi.org\/10.1007\/s00216-018-1260-y.","journal-title":"Anal Bioanal Chem"},{"issue":"5","key":"286_CR20","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1177\/0748233710388452","volume":"27","author":"O Ciftci","year":"2011","unstructured":"Ciftci O, Ozdemir I, Tanyildizi S, Yildiz S, Oguzturk H. Antioxidative effects of Curcumin, \u03b2-myrcene and 1,8-cineole against 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced oxidative stress in rats liver. Toxicol Ind Health. 2011;27(5):447\u201353. https:\/\/doi.org\/10.1177\/0748233710388452.","journal-title":"Toxicol Ind Health"},{"key":"286_CR21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000534610","volume":"6","author":"V Degrave","year":"2023","unstructured":"Degrave V, Vega Joubert MB, Ingaramo P, Sedan D, Andrinolo D, D\u2019Alessandro ME, et al. Effects of Full-Spectrum Cannabis oil with a Cannabidiol:Tetrahydrocannabinol 2:1 ratio on the mechanisms involved in hepatic steatosis and oxidative stress in rats fed a Sucrose-Rich diet. Med Cannabis Cannabinoids. 2023a;6:170\u201383. https:\/\/doi.org\/10.1159\/000534610.","journal-title":"Med Cannabis Cannabinoids"},{"key":"286_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.31487\/j.JFNM.2023.01.01","volume":"6","author":"V Degrave","year":"2023","unstructured":"Degrave V, Vega Joubert MB, Vaccarini C, Sedan D, Andrinolo D, D\u2019Alessandro ME. Effects of Cannabis oil on cannabinoid-tnduced Tetrad, blood pressure, and metabolic parameters in an experimental model of metabolic syndrome. J Food Nutr Metabol. 2023b;6:1\u20139. https:\/\/doi.org\/10.31487\/j.JFNM.2023.01.01.","journal-title":"J Food Nutr Metabol"},{"key":"286_CR23","doi-asserted-by":"publisher","unstructured":"Dibba P, Li A, Cholankeril G, Iqbal U, Gadiparthi C, Khan MA, Kim D, Ahmed A. Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease. Medicines (Basel). 2018; 28;5(2):47. https:\/\/doi.org\/10.3390\/medicines5020047","DOI":"10.3390\/medicines5020047"},{"issue":"5","key":"286_CR24","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1021\/acschemneuro.0c00075","volume":"4","author":"EJ Downer","year":"2020","unstructured":"Downer EJ. Anti-inflammatory potential of terpenes present in Cannabis sativa L. ACS Chem Neurosci. 2020;4(5):659\u201362. https:\/\/doi.org\/10.1021\/acschemneuro.0c00075.","journal-title":"ACS Chem Neurosci"},{"key":"286_CR25","doi-asserted-by":"publisher","first-page":"12705402","DOI":"10.3389\/fphar.2021.705402","volume":"21","author":"OL Erukainure","year":"2021","unstructured":"Erukainure OL, Matsabisa MG, Salau VF, Oyedemi SO, Oyenihi OR, Ibeji CU, Islam MS. Cannabis sativa L. (var. indica) exhibits hepatoprotective effects by modulating hepatic lipid profile and mitigating gluconeogenesis and cholinergic dysfunction in oxidative hepatic injury. Front Pharmacol. 2021;21:12705402. https:\/\/doi.org\/10.3389\/fphar.2021.705402.","journal-title":"Front Pharmacol"},{"issue":"9","key":"286_CR26","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.3390\/molecules24091694","volume":"30","author":"LE Ewing","year":"2019","unstructured":"Ewing LE, Skinner CM, Quick CM, Kennon-McGill S, McGill MR, Walker LA, ElSohly MA, Gurley BJ, Koturbash I. Hepatotoxicity of a Cannabidiol-Rich Cannabis extract in the mouse model. Molecules. 2019;30(9):1694. https:\/\/doi.org\/10.3390\/molecules24091694.","journal-title":"Molecules"},{"key":"286_CR27","doi-asserted-by":"publisher","unstructured":"Flores-Cortez D, Villalobos-Pacheco E, Ignacio-Punin C, Gutierrez-Guerra G, Tovar-Brandan J, Rodriguez-Tafur J. Hepatoprotective effect of cannabidiol on the progression of experimental hepatic cirrhosis in rats. Cannabis Cannabinoid Res. 2025;10(2):228\u201335. https:\/\/doi.org\/10.1089\/can.2023.0285.","DOI":"10.1089\/can.2023.0285"},{"key":"286_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.plefa.2016.11.003","volume":"116","author":"MA Fortino","year":"2017","unstructured":"Fortino MA, Oliva ME, Rodriguez S, Lombardo YB, Chicco A. Could post-weaning dietary Chia seed mitigate the development of dyslipidemia, liver steatosis and altered glucose homeostasis in offspring exposed to a sucrose-rich diet from utero to adulthood? Prostaglandins Leukot Essent Fat Acids. 2017;116:19\u201326. https:\/\/doi.org\/10.1016\/j.plefa.2016.11.003.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"issue":"7","key":"286_CR30","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908\u201322. https:\/\/doi.org\/10.1038\/s41591-018-0104-9.","journal-title":"Nat Med"},{"key":"286_CR31","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-Berumen CI, Ortiz-Avila O, Vargas-Vargas MA, Del Rosario-Tamayo BA, Guajardo-L\u00f3pez C, Saavedra-Molina A, Rodr\u00edguez-Orozco AR, Cort\u00e9s-Rojo C. The severity of rat liver injury by fructose and high fat depends on the degree of respiratory dysfunction and oxidative stress induced in mitochondria. Lipids Health Dis. 2019; 30;18(1):78. https:\/\/doi.org\/10.1186\/s12944-019-1024-5.","DOI":"10.1186\/s12944-019-1024-5."},{"issue":"26","key":"286_CR33","doi-asserted-by":"publisher","first-page":"9099","DOI":"10.1073\/pnas.0803601105","volume":"1","author":"J Gertsch","year":"2008","unstructured":"Gertsch J, Leonti M, Raduner S, Racz I, Chen JZ, Xie XQ, Altmann KH, Karsak M, Zimmer A. Beta-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci U S A. 2008;1(26):9099\u2013104. https:\/\/doi.org\/10.1073\/pnas.0803601105.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"286_CR32","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.tem.2022.08.003","volume":"33","author":"E Ghasemi-Gojani","year":"2022","unstructured":"Ghasemi-Gojani E, Kovalchuk I, Kovalchuk O. Cannabinoids and terpenes for diabetes mellitus and its complications: from mechanisms to new therapies. Trends Endocrinol Metab. 2022;33(12):828\u201349. https:\/\/doi.org\/10.1016\/j.tem.2022.08.003.","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"286_CR34","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/bph.13226","volume":"173","author":"G Gruden","year":"2016","unstructured":"Gruden G, Barutta F, Kunos G, Pacher P. Role of the endocannabinoid system in diabetes and diabetic complications. Br J Pharmacol. 2016;173(7):1116\u201327. https:\/\/doi.org\/10.1111\/bph.13226.","journal-title":"Br J Pharmacol"},{"issue":"14","key":"286_CR35","doi-asserted-by":"publisher","first-page":"8268","DOI":"10.1073\/pnas.95.14.8268","volume":"95","author":"AJ Hampson","year":"1998","unstructured":"Hampson AJ, Grimaldi M, Axelrod J, Wink D. Cannabidiol and (-) Delta9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci U S A. 1998;95(14):8268\u201373. https:\/\/doi.org\/10.1073\/pnas.95.14.8268.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"286_CR36","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/mp.2011.82","volume":"17","author":"J Hirvonen","year":"2012","unstructured":"Hirvonen J, Goodwin RS, Li CT, Terry GE, Zoghbi SS, Morse C, Pike VW, Volkow ND, Huestis MA, Innis RB. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol Psychiatry. 2012;17(6):642\u20139. https:\/\/doi.org\/10.1038\/mp.2011.82.","journal-title":"Mol Psychiatry"},{"key":"286_CR37","unstructured":"ICH Q2(R2.), Guideline on validation of analytical procedures. https:\/\/database.ich.org\/sites\/default\/files\/ICH_Q2-R2_Document_Step2_Guideline_2022_0324.pdf"},{"key":"286_CR38","doi-asserted-by":"publisher","first-page":"e93760","DOI":"10.1172\/jci.insight.93760","volume":"2","author":"KA Jadoon","year":"2017","unstructured":"Jadoon KA, Tan GD, O\u2019Sullivan SE. A single dose of Cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study. JCI Insight. 2017;2:e93760. https:\/\/doi.org\/10.1172\/jci.insight.93760.","journal-title":"JCI Insight"},{"issue":"5","key":"286_CR39","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","volume":"68","author":"T Jensen","year":"2018","unstructured":"Jensen T, Abdelmalek MF, Sullivan S, Nadeau KJ, Green M, Roncal C, Nakagawa T, Kuwabara M, Sato Y, Kang DH, Tolan DR, Sanchez-Lozada LG, Rosen HR, Lanaspa MA, Diehl AM, Johnson RJ. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. J Hepatol. 2018;68(5):1063\u201375. https:\/\/doi.org\/10.1016\/j.jhep.2018.01.019.","journal-title":"J Hepatol"},{"issue":"12","key":"286_CR41","doi-asserted-by":"publisher","first-page":"724747","DOI":"10.3389\/fphar.2021.724747","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Gu Y, Huang Y, Zhou Y, Pang N, Luo J, Tang Z, Zhang Z, Yang L. CBD alleviates liver injuries in alcoholics with High-Fat High-Cholesterol diet through regulating NLRP3 Inflammasome-Pyroptosis pathway. Front Pharmacol. 2021;22(12):724747. https:\/\/doi.org\/10.3389\/fphar.2021.724747.","journal-title":"Front Pharmacol"},{"issue":"1\u20133","key":"286_CR40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ejphar.2013.06.022","volume":"5","author":"L Jing","year":"2013","unstructured":"Jing L, Zhang Y, Fan S, Gu M, Guan Y, Lu X, Huang C, Zhou Z. Preventive and ameliorating effects of citrus d-limonene on dyslipidemia and hyperglycemia in mice with high-fat diet-induced obesity. Eur J Pharmacol. 2013;5(1\u20133):46\u201355. https:\/\/doi.org\/10.1016\/j.ejphar.2013.06.022.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"286_CR42","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2174\/0929867327666200303122734","volume":"28","author":"B Jorga\u010devi\u0107","year":"2021","unstructured":"Jorga\u010devi\u0107 B, Vu\u010devi\u0107 D, Samard\u017ei\u0107 J, Mladenovi\u0107 D, Veskovi\u0107 M, Vuki\u0107evi\u0107 D, Je\u0161i\u0107 R, Radosavljevi\u0107 T. The effect of CB1 antagonism on hepatic oxidative\/nitrosative stress and inflammation in nonalcoholic fatty liver disease. Curr Med Chem. 2021;28(1):169\u201380. https:\/\/doi.org\/10.2174\/0929867327666200303122734.","journal-title":"Curr Med Chem"},{"issue":"5","key":"286_CR43","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1080\/19390211.2020.1790708","volume":"17","author":"E Karimian Azari","year":"2020","unstructured":"Karimian Azari E, Kerrigan A, O\u2019Connor A. Naturally occurring cannabinoids and their role in modulation of cardiovascular health. J Diet Suppl. 2020;17(5):625\u201350. https:\/\/doi.org\/10.1080\/19390211.2020.1790708.","journal-title":"J Diet Suppl"},{"key":"286_CR44","doi-asserted-by":"publisher","unstructured":"Kim T, Mijan MA, Lee J, et al. Essential oils for the treatment and management of nonalcoholic fatty liver disease (NAFLD). Nat Prod Commun. 2024;19(4). https:\/\/doi.org\/10.1177\/1934578X241250248.","DOI":"10.1177\/1934578X241250248"},{"issue":"5","key":"286_CR45","doi-asserted-by":"publisher","first-page":"e70009","DOI":"10.1002\/prp2.70009","volume":"12","author":"M Kurtov","year":"2024","unstructured":"Kurtov M, Rubini\u0107 I, Liki\u0107 R. The endocannabinoid system in appetite regulation and treatment of obesity. Pharmacol Res Perspect. 2024;12(5):e70009. https:\/\/doi.org\/10.1002\/prp2.70009.","journal-title":"Pharmacol Res Perspect"},{"key":"286_CR46","doi-asserted-by":"publisher","unstructured":"Kutanzi KR, Ewing LE, Skinner CM, Quick CM, Kennon-McGill S, McGill MR, Walker LA, ElSohly MA, Gurley BJ, Koturbash I. Safety and Molecular-Toxicological Implications of Cannabidiol-Rich Cannabis Extract and Methylsulfonylmethane Co-Administration. Int J Mol Sci. 2020; 21;21(20):7808. https:\/\/doi.org\/10.3390\/ijms21207808","DOI":"10.3390\/ijms21207808"},{"issue":"1","key":"286_CR47","doi-asserted-by":"publisher","first-page":"8232","DOI":"10.1038\/s41598-021-87740-8","volume":"15","author":"JE LaVigne","year":"2021","unstructured":"LaVigne JE, Hecksel R, Keresztes A, Streicher JM. Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity. Sci Rep. 2021;15(1):8232. https:\/\/doi.org\/10.1038\/s41598-021-87740-8.","journal-title":"Sci Rep"},{"issue":"8","key":"286_CR48","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/aje\/kwr200","volume":"15","author":"Y Le Strat","year":"2011","unstructured":"Le Strat Y, Le Foll B. Obesity and cannabis use: results from 2 representative National surveys. Am J Epidemiol. 2011;15(8):929\u201333. https:\/\/doi.org\/10.1093\/aje\/kwr200.","journal-title":"Am J Epidemiol"},{"key":"286_CR49","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12906-020-03182-1","volume":"21","author":"W Li","year":"2021","unstructured":"Li W, Jiang L, Lu X, Liu X, Ling M. Curcumin protects radiation-induced liver damage in rats through the NF-\u03baB signaling pathway. BMC Complement Med Ther. 2021;21:10. https:\/\/doi.org\/10.1186\/s12906-020-03182-1.","journal-title":"BMC Complement Med Ther"},{"issue":"4","key":"286_CR50","doi-asserted-by":"publisher","first-page":"150276","DOI":"10.1098\/rsob.150276","volume":"6","author":"C Lipina","year":"2016","unstructured":"Lipina C, Hundal HS. Modulation of cellular redox homeostasis by the endocannabinoid system. Open Biol. 2016;6(4):150276. https:\/\/doi.org\/10.1098\/rsob.150276.","journal-title":"Open Biol"},{"issue":"6","key":"286_CR51","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/joim.13627","volume":"293","author":"LA Lo","year":"2023","unstructured":"Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023;293(6):724\u201352. https:\/\/doi.org\/10.1111\/joim.13627.","journal-title":"J Intern Med"},{"issue":"7","key":"286_CR52","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/j.1476-5381.2011.01397.x","volume":"163","author":"A Mallat","year":"2011","unstructured":"Mallat A, Teixeira-Clerc F, Deveaux V, Manin S, Lotersztajn S. The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings. Br J Pharmacol. 2011;163(7):1432\u201340. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01397.x.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"286_CR53","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jhep.2013.03.032","volume":"59","author":"A Mallat","year":"2013","unstructured":"Mallat A, Teixeira-Clerc F, Lotersztajn S. Cannabinoid signaling and liver therapeutics. J Hepatol. 2013;59(4):891\u20136. https:\/\/doi.org\/10.1016\/j.jhep.2013.03.032.","journal-title":"J Hepatol"},{"key":"286_CR54","doi-asserted-by":"publisher","unstructured":"Masyita A, Mustika Sari R, Dwi Astuti A, Yasir B, Rahma Rumata N, Emran TB, Nainu F, Simal-Gandara J. Terpenes and terpenoids as main bioactive compounds of essential oils, their roles in human health and potential application as natural food preservatives. Food Chem X. 2022; 19;13:100217. https:\/\/doi.org\/10.1016\/j.fochx.2022.100217","DOI":"10.1016\/j.fochx.2022.100217"},{"issue":"16","key":"286_CR55","doi-asserted-by":"publisher","first-page":"9423","DOI":"10.3390\/ijms23169423","volume":"23","author":"RS Mboumba Bouassa","year":"2022","unstructured":"Mboumba Bouassa RS, Sebastiani G, Di Marzo V, Jenabian MA, Costiniuk CT. Cannabinoids and chronic liver diseases. Int J Mol Sci. 2022;23(16):9423. https:\/\/doi.org\/10.3390\/ijms23169423.","journal-title":"Int J Mol Sci"},{"key":"286_CR56","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ejmech.2018.07.076","volume":"157","author":"T Nuutinen","year":"2018","unstructured":"Nuutinen T. Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus. Eur J Med Chem. 2018;157:198\u2013228. https:\/\/doi.org\/10.1016\/j.ejmech.2018.07.076.","journal-title":"Eur J Med Chem"},{"issue":"5","key":"286_CR57","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1172\/JCI23057","volume":"115","author":"D Osei-Hyiaman","year":"2005","unstructured":"Osei-Hyiaman D, DePetrillo M, Pacher P, Liu J, Radaeva S, B\u00e1tkai S, Harvey-White J, Mackie K, Offert\u00e1ler L, Wang L, Kunos G. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest. 2005;115(5):1298\u2013305. https:\/\/doi.org\/10.1172\/JCI23057.","journal-title":"J Clin Invest"},{"key":"286_CR58","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.3390\/ijms24032513","volume":"24","author":"C Pagano","year":"2023","unstructured":"Pagano C, Savarese B, Coppola L, Navarra G, Avilia G, Laezza C, Bifulco M. Cannabinoids in the modulation of oxidative signaling. Int J Mol Sci. 2023;24:2513. https:\/\/doi.org\/10.3390\/ijms24032513.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"286_CR59","doi-asserted-by":"publisher","first-page":"NS20200080","DOI":"10.1042\/NS20200080","volume":"24","author":"SR Pereira","year":"2021","unstructured":"Pereira SR, Hackett B, O\u2019Driscoll DN, Sun MC, Downer EJ. Cannabidiol modulation of oxidative stress and signalling. Neuronal Signal. 2021;24(3):NS20200080. https:\/\/doi.org\/10.1042\/NS20200080.","journal-title":"Neuronal Signal"},{"issue":"2","key":"286_CR60","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","volume":"153","author":"RG Pertwee","year":"2008","unstructured":"Pertwee RG. The diverse CB1 and CB2 receptor Pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, Cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol. 2008;153(2):199\u2013215. https:\/\/doi.org\/10.1038\/sj.bjp.0707442.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"286_CR61","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1055\/s-0034-1387169","volume":"23","author":"K Prasad","year":"2014","unstructured":"Prasad K, Dhar I. Oxidative stress as a mechanism of added sugar-induced cardiovascular disease. Int J Angiol. 2014;23(4):217\u201326. https:\/\/doi.org\/10.1055\/s-0034-1387169.","journal-title":"Int J Angiol"},{"issue":"2","key":"286_CR62","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1208\/s12248-010-9178-0","volume":"12","author":"V Purohit","year":"2010","unstructured":"Purohit V, Rapaka R, Shurtleff D. Role of cannabinoids in the development of fatty liver (steatosis). AAPS J. 2010;12(2):233\u20137. https:\/\/doi.org\/10.1208\/s12248-010-9178-0.","journal-title":"AAPS J"},{"issue":"25","key":"286_CR63","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/j.jacc.2010.07.033","volume":"56","author":"M Rajesh","year":"2010","unstructured":"Rajesh M, Mukhopadhyay P, B\u00e1tkai S, Patel V, Saito K, Matsumoto S, Kashiwaya Y, Horv\u00e1th B, Mukhopadhyay B, Becker L, Hask\u00f3 G, Liaudet L, Wink DA, Veves A, Mechoulam R, Pacher P. Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. J Am Coll Cardiol. 2010;56(25):2115\u201325. https:\/\/doi.org\/10.1016\/j.jacc.2010.07.033.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"286_CR64","doi-asserted-by":"publisher","first-page":"716","DOI":"10.2337\/db11-0477","volume":"61","author":"M Rajesh","year":"2012","unstructured":"Rajesh M, B\u00e1tkai S, Kechrid M, Mukhopadhyay P, Lee WS, Horv\u00e1th B, Holovac E, Cinar R, Liaudet L, Mackie K, Hask\u00f3 G, Pacher P. Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy. Diabetes. 2012;61(3):716\u201327. https:\/\/doi.org\/10.2337\/db11-0477.","journal-title":"Diabetes"},{"issue":"14","key":"286_CR65","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1111\/bph.15051","volume":"177","author":"P Rivera","year":"2020","unstructured":"Rivera P, Vargas A, Pastor A, Boronat A, L\u00f3pez-Gambero AJ, S\u00e1nchez-Mar\u00edn L, Medina-Vera D, Serrano A, Pav\u00f3n FJ, de la Torre R, Agirregoitia E, Lucena MI, Rodr\u00edguez de Fonseca F, Decara J, Su\u00e1rez J. Differential hepatoprotective role of the cannabinoid CB1 and CB2 receptors in paracetamol-induced liver injury. Br J Pharmacol. 2020;177(14):3309\u201326. https:\/\/doi.org\/10.1111\/bph.15051.","journal-title":"Br J Pharmacol"},{"issue":"7","key":"286_CR66","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","volume":"163","author":"EB Russo","year":"2011","unstructured":"Russo EB, Taming THC. Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344\u201364. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01238.x.","journal-title":"Br J Pharmacol"},{"key":"286_CR67","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1021\/acs.jnatprod.9b01200","volume":"83","author":"ND Sarma","year":"2020","unstructured":"Sarma ND, Waye A, ElSohly MA, Brown PN, Elzinga S, Johnson HE, Marles RJ, Melanson JE, Russo E, Deyton L, Hudalla C, Vrdoljak GA, Wurzer JH, Khan IA, Kim NC, Giancaspro GI. Cannabis inflorescence for medical purposes: USP considerations for quality attributes. J Nat Prod. 2020;83:1334\u201351. https:\/\/doi.org\/10.1021\/acs.jnatprod.9b01200.","journal-title":"J Nat Prod"},{"issue":"1","key":"286_CR68","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/13543776.2019.1558211","volume":"29","author":"EAP Silva","year":"2019","unstructured":"Silva EAP, Carvalho JS, Guimar\u00e3es AG, Barreto RSS, Santos MRV, Barreto AS, Quintans-J\u00fanior LJ. The use of terpenes and derivatives as a new perspective for cardiovascular disease treatment: a patent review (2008\u20132018). Expert Opin Ther Pat. 2019;29(1):43\u201353. https:\/\/doi.org\/10.1080\/13543776.2019.1558211.","journal-title":"Expert Opin Ther Pat"},{"issue":"4","key":"286_CR69","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.cmet.2013.03.001","volume":"17","author":"C Silvestri","year":"2013","unstructured":"Silvestri C, Di Marzo V. The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders. Cell Metab. 2013;17(4):475\u201390. https:\/\/doi.org\/10.1016\/j.cmet.2013.03.001.","journal-title":"Cell Metab"},{"issue":"3","key":"286_CR70","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11154-011-9167-3","volume":"12","author":"C Silvestri","year":"2011","unstructured":"Silvestri C, Ligresti A, Di Marzo V. Peripheral effects of the endocannabinoid system in energy homeostasis: adipose tissue, liver and skeletal muscle. Rev Endocr Metab Disord. 2011;12(3):153\u201362. https:\/\/doi.org\/10.1007\/s11154-011-9167-3.","journal-title":"Rev Endocr Metab Disord"},{"issue":"6","key":"286_CR71","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/j.jhep.2015.01.001","volume":"62","author":"C Silvestri","year":"2015","unstructured":"Silvestri C, Paris D, Martella A, Melck D, Guadagnino I, Cawthorne M, Motta A, Di Marzo V. Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis. J Hepatol. 2015;62(6):1382\u201390. https:\/\/doi.org\/10.1016\/j.jhep.2015.01.001.","journal-title":"J Hepatol"},{"issue":"6","key":"286_CR72","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1111\/bcp.14225","volume":"86","author":"SR Sultan","year":"2020","unstructured":"Sultan SR, O\u2019Sullivan SE, England TJ. The effects of acute and sustained Cannabidiol dosing for seven days on the haemodynamics in healthy men: A randomised controlled trial. Br J Clin Pharmacol. 2020;86(6):1125\u201338. https:\/\/doi.org\/10.1111\/bcp.14225.","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"286_CR73","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1111\/bph.15010","volume":"177","author":"S Tan","year":"2020","unstructured":"Tan S, Liu H, Ke B, Jiang J, Wu B. The peripheral CB1 receptor antagonist JD5037 attenuates liver fibrosis via a CB1 receptor\/\u03b2-arrestin1\/Akt pathway. Br J Pharmacol. 2020;177(12):2830\u201347. https:\/\/doi.org\/10.1111\/bph.15010.","journal-title":"Br J Pharmacol"},{"key":"286_CR74","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3920\/BM2017.0127","volume":"9","author":"S Tillmann","year":"2018","unstructured":"Tillmann S, Wegener G. Syringe-feeding as a novel delivery method for accurate individual dosing of probiotics in rats. Benef Microbes. 2018;9:311\u201315. https:\/\/doi.org\/10.3920\/BM2017.0127.","journal-title":"Benef Microbes"},{"key":"286_CR75","first-page":"614","volume":"50","author":"PV Turner","year":"2011","unstructured":"Turner PV, Pekow C, Vasbinder MA, Brabb T. Administration of substances to laboratory animals: equipment considerations, vehicle selection, and solute Preparation. JAALAS. 2011;50:614\u201327.","journal-title":"JAALAS"},{"key":"286_CR76","doi-asserted-by":"publisher","unstructured":"Vall\u00e9e A. Association between cannabis use and blood pressure levels according to comorbidities and socioeconomic status. Sci Rep 2023 5;13(1):2069. https:\/\/doi.org\/10.1038\/s41598-022-22841-6","DOI":"10.1038\/s41598-022-22841-6"},{"key":"286_CR77","doi-asserted-by":"publisher","first-page":"11249","DOI":"10.1039\/d2fo02216h","volume":"13","author":"MB Vega Joubert","year":"2022","unstructured":"Vega Joubert MB, Degrave V, Ingaramo P, Oliva ME, D\u2019Alessandro ME. Salvia hispanica L. (chia) seed improves liver inflammation and endothelial dysfunction in an experimental model of metabolic syndrome. Food Funct. 2022;13:11249. https:\/\/doi.org\/10.1039\/d2fo02216h.","journal-title":"Food Funct"},{"issue":"1","key":"286_CR78","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00394-011-0182-7","volume":"51","author":"J Victor Antony Santiago","year":"2012","unstructured":"Victor Antony Santiago J, Jayachitra J, Shenbagam M, Nalini N. Dietary d-limonene alleviates insulin resistance and oxidative stress-induced liver injury in high-fat diet and L-NAME-treated rats. Eur J Nutr. 2012;51(1):57\u201368. https:\/\/doi.org\/10.1007\/s00394-011-0182-7.","journal-title":"Eur J Nutr"},{"issue":"1","key":"286_CR81","doi-asserted-by":"publisher","first-page":"12064","DOI":"10.1038\/s41598-017-10924-8","volume":"21","author":"Y Wang","year":"2017","unstructured":"Wang Y, Mukhopadhyay P, Cao Z, Wang H, Feng D, Hask\u00f3 G, Mechoulam R, Gao B, Pacher P. Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury. Sci Rep. 2017;21(1):12064. https:\/\/doi.org\/10.1038\/s41598-017-10924-8.","journal-title":"Sci Rep"},{"issue":"5","key":"286_CR82","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/cpt.2071","volume":"109","author":"PB Watkins","year":"2021","unstructured":"Watkins PB, Church RJ, Li J, Knappertz V. Cannabidiol and abnormal liver chemistries in healthy adults: results of a phase I clinical trial. Clin Pharmacol Ther. 2021;109(5):1224\u201331. https:\/\/doi.org\/10.1002\/cpt.2071.","journal-title":"Clin Pharmacol Ther"},{"key":"286_CR79","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.freeradbiomed.2013.12.026","volume":"68","author":"L Yang","year":"2014","unstructured":"Yang L, Rozenfeld R, Wu D, Devi LA, Zhang Z, Cederbaum A. Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including Inhibition of oxidative stress and increase in autophagy. Free Radic Biol Med. 2014;68:260\u20137. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.12.026.","journal-title":"Free Radic Biol Med"},{"key":"286_CR80","doi-asserted-by":"publisher","unstructured":"Yao P, Liu Y, Terpenoids. Natural compounds for Non-Alcoholic fatty liver disease (NAFLD). Therapy Molecules. 2022;29(1):272. https:\/\/doi.org\/10.3390\/molecules28010272.","DOI":"10.3390\/molecules28010272"},{"key":"286_CR83","doi-asserted-by":"publisher","first-page":"7964018","DOI":"10.1155\/2022\/7964018","volume":"26","author":"G Zandani","year":"2022","unstructured":"Zandani G, Anavi-Cohen S, Assa-Glazer T, Gorelick J, Nyska A, Sela N, Bernstein N, Madar Z. Cannabis extract effects on metabolic parameters and gut microbiota composition in a mice model of NAFLD and obesity. Evid Based Complement Alternat Med. 2022;26:7964018. https:\/\/doi.org\/10.1155\/2022\/7964018.","journal-title":"Evid Based Complement Alternat Med"}],"container-title":["Journal of Cannabis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-025-00286-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42238-025-00286-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-025-00286-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T16:53:39Z","timestamp":1752512019000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcannabisresearch.biomedcentral.com\/articles\/10.1186\/s42238-025-00286-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["286"],"URL":"https:\/\/doi.org\/10.1186\/s42238-025-00286-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6031156\/v1","asserted-by":"object"}]},"ISSN":["2522-5782"],"issn-type":[{"value":"2522-5782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"14 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in strict accordance with the NIH guidelines for the care and use of laboratory animals and approved by the Institutional Ethics Committee of the Faculty of Biochemistry and Biological Sciences (UNL, Santa Fe, Argentine - Acta CE2022-63). Not applicable for consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final manuscript and consent to its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}